4์ฃผ์ฐจ (3/28) : I

Inflammatory CNS disease (์—ผ์ฆ์„ฑ ๋‡Œ์งˆํ™˜)

  • Granuloma : ๊ฐ์—ผ์ด ์—†๋Š” ์ƒํƒœ์—์„œ macrophage & lymphocyte๊ฐ€ ํ˜ผ์žฌ๋œ ์ƒํƒœ๋กœ ์กด์žฌ.
  • ์—ผ์ฆ์„ธํฌ๊ฐ€ ๋งŽ์ด ์กด์žฌ โ†’ ๋น„์ค‘(SG) ๋†’์Œ, protein ๋†๋„ ๋†’์Œ.
  • Mononuclear cell(๋‹จํ•ต์„ธํฌ) ์ฆ๊ฐ€ - ์ฃผ๋กœ monocyte, lymphocyte ์ฆ๊ฐ€
    • GME๋Š” ๋Œ€๋ถ€๋ถ„ lymphocyte ์นจ์œค (T๋ฆผํ”„๊ตฌ > B๋ฆผํ”„๊ตฌ)
Inflammatory CNS disease
InfectiousNon-infectious
- Fungal : ์šฐ๋ฆฌ๋‚˜๋ผ๋Š” rare.
- Bacterial : uncommon
- Protozoal : uncommon - Babesiosis
- Rickettia : uncommon
- Immune mediated, autoimmune : common

CSF

CSF : cerebrospinal fluid (๋‡Œ์ฒ™์ˆ˜์•ก)

  • ๋ง‘๊ณ (clear) ํˆฌ๋ช…(colorless)
  • Protein content : < 20mg/ml
  • WBC : < 6cells/ul ์ดํ•˜๋กœ ์กด์žฌ
  • small lymphocyte๊ฐ€ ๋งŽ์Œ
  • ๋‡Œ์•• : < 173 mmH2O
CSF ์†Œ๊ฒฌ
Increased cells & porteins ๋Š” ๋ชจ๋‘ ๊ณตํ†ต !!
Inflammatory- ์—ผ์ฆ, ๋ฐ”์ด๋Ÿฌ์Šค์„ฑ ์งˆํ™˜ :
โœ”๏ธ cell count : > 6cells/ul
โœ”๏ธ ๋‹จ๋ฐฑ์งˆ ๋†๋„ : > 25mg/ml
โœ”๏ธ Mononuclear cells ์ฆ๊ฐ€ (lymphocytes, reactive macrophages)
Fungal- Cryptococcosis :
โœ”๏ธ Mixed cell population
(lymphocyte, reactive macrophage, neutrophils ๋“ฑ์ด ํ˜ผ์žฌ)
โœ”๏ธ Capsulated, budding yeast๊ฐ€ ๋ณผ๋ก ๋ณด์ž„
Bacterial- Septic spinal tap
โœ”๏ธ Neutrophil์ด ํ›จ์”ฌ ๋งŽ์Œ
โœ”๏ธ cultureํ•ด์„œ ์„ธ๊ท  ํ™•์ธ
Neoplasia- Lymphosarcoma๊ฐ€ ๋งŽ์Œ
โœ”๏ธ neoplastic cells ์ฆ๊ฐ€
(choroid plexus papillomas, ependymomas, lymphosarcoma์—์„œ ๋‚˜ํƒ€๋‚จ)

CSF Titer ๊ฒ€์‚ฌ : Viral & Protozoal

  • ํ˜ˆ์ฒญ์—์„œ์˜ titer์™€ ๋‡Œ์ฒ™์ˆ˜์•ก์˜ titer๋ฅผ ๋น„๊ต ํ‰๊ฐ€ (paired serum and CSF)
  • Before/After๋ฅผ ๋น„๊ต. 2์ฃผ ๊ฐ„๊ฒฉ์œผ๋กœ ๊ฒ€์‚ฌํ•˜์—ฌ ์ˆ˜์น˜๊ฐ€ 4๋ฐฐ ์ด์ƒ ์˜ฌ๋ผ๊ฐ€๋ฉด ๊ฐ์—ผ๋œ ๊ฒƒ.
  • ์ง€๊ธˆ์€ ์ž˜ ์•ˆ ์“ด๋‹ค. CSF ๋ฝ‘์•„์„œ real-time PCR ๋Œ๋ฆฌ๋ฉด ๋˜๋‹ˆ๊นŒ..
ํ˜ˆ์ฒญCSF๊ฒฐ๊ณผ
๋†’์Œ๋‚ฎ์Œ๋ฐฑ์‹  ๊ฐ€๋Šฅ์„ฑ โ†‘
๋†’์Œ๋†’์Œ
(ํŠนํžˆ 2์ฃผ ๋’ค ํ›จ์”ฌ ์ฆ๊ฐ€ํ–ˆ์œผ๋ฉด)
๊ฐ์—ผ ๊ฐ€๋Šฅ์„ฑ โ†‘
(BBB ํ†ต๊ณผ)
CSF Titer
์—ผ์ฆ์˜ ์ฆ๊ฑฐ๊ฐ€ ์žˆ๋“  ์—†๋“  ๊ฒ€์‚ฌ
Viral- Canine distemper / FeLV, FIP
Protozoal- Toxoplasma, Neospora caninus (๋‡Œ๊นŒ์ง€ ๋„๋‹ฌ)
์—ผ์ฆ์˜ ์ฆ๊ฑฐ๊ฐ€ ์žˆ์„ ๋•Œ ๊ฒ€์‚ฌ
Fungal- Aspergillus / Cryptococcus
Rickettsial- RMSF (Rocky Mountain Spotted Fever) / Erhlichia
Bacterial- Borrelia (Borrelia burgdorferi ๊ฐ์—ผ โ†’ Lyme disease)

๐Ÿ“‹ Case 1 : Bacterial Meningoencephalitis

S

4y, Male, Miniature pinscher

  • 5.4kg, 39.0โ„ƒ, 150ํšŒ/min (์ •์ƒ ์ฒด์˜จ, ์ •์ƒ ์ฒด์ค‘)
  • Acute onset : stiffness, head tilt, nystagmus

โ‡’ ์ „ํ˜•์ ์ธ vestibular sign

  • Lt. side SLMN swelling (1๋‹ฌ ์ „) โ‡’ ํ•ญ์ƒ์ œ ํˆฌ์—ฌ ํ›„ ๊ฐœ์„ , ์„ธ๊ท  ๊ฐ์—ผ ์ถ”์ •
    (SLMN = Spinal Lower Motor Neuron, ์ฒ™์ˆ˜ ํ•˜์œ„ ์šด๋™ ๋‰ด๋Ÿฐ)
O
Physical exmination
- Left side head tilt, tetraparesis
- Horizontal & Positional nystagmus โ‡’ CN โ…ข, โ…ฃ, โ…ฅ & โ…ง
- Delayed postural reactions
- Delayed PLR โ‡’ CN โ…ก & โ…ข
- Reduced gagging reflex โ‡’ CN โ…จ & โ…ฉ (์นจ ์‚ผํ‚ด ๊ด€๋ จ ์‹ ๊ฒฝ)

โ‡’ ๋‡Œ ์ „์ฒด์— multifocalํ•˜๊ฒŒ ๋ฌธ์ œ (Brain & Brainstem)
Blood examination
Moderate neutrophilic leukocytosis
EEG
Brain CT
๋‡Œ ์•ˆ์—์„œ multifocal ์—ผ์ฆ ์†Œ๊ฒฌ
(์†Œ๋‡Œ, ์ค‘๋‡Œ, ๋‡Œ์ค„๊ธฐ ์˜์—ญ์— ํ•˜์–—๊ฒŒ ์—ผ์ฆ)
- ๊ณ ํ•ด์ƒ๋„(0.2T)๋กœ ๋ณด๋‹ˆ, ์†Œ๋‡Œ์™€ ์—ฐ์ˆ˜์˜ ์—ฐ๊ฒฐ ๋ถ€์œ„์—์„œ ์‹ฌํ•œ ๋ณ‘๋ณ€ (vestibular sign ๊ด€๋ จ)
(*์ „์ • ์ชฝ ๋ณ‘๋ณ€ : ์†Œ๋‡Œ ์ผ๋ถ€, flocculondular lobe, medulla oblangata, ๋‚ด์ด)
- ๊ทธ ์™ธ ๋‡Œ์ค„๊ธฐ, ๋Œ€๋‡Œ ๋ฐ˜๊ตฌ์—์„œ๋„ ์‹ฌํ•œ ์—ผ์ฆ ์†Œ๊ฒฌ.
โ‡’ Midbrain + diencephalon์— multifocalํ•œ ์—ผ์ฆ ์†Œ๊ฒฌ. (๋‡Œ์ˆ˜๋ง‰์—ผ)
CSF ๊ฒ€์‚ฌ
- Neutrophilic pleocytosis (neutrophil๋งŒ ์—„์ฒญ ๋‚˜์˜ด)โ†’ Bacteria ๊ฐ์—ผ ์˜์‹ฌ.
- ์„ธ๊ท  ๊ฐ์—ผ ์‹œ โ†’ ํ™”๋†์„ฑ(suppurative) ๋ณ‘๋ณ€ = neutrophil ๋งŽ์Œ.
- ํ•ญ์ƒ์ œ ํˆฌ์—ฌ ํ›„ ๋ฆผํ”„์ ˆ ๋น„๋Œ€๊ฐ€ ํ•ด์†Œ๋˜์—ˆ๋˜ ๊ฒƒ๋„ ์„ธ๊ท ์„ฑ ๊ฐ์—ผ ์ถ”์ •์˜ ๊ทผ๊ฑฐ
โ‡’ ์„ธ๊ท  ๊ฐ์—ผ์œผ๋กœ ์ธํ•œ active intracranial inflammation
A

Dx) Bacterial meningoencephalitis (BME, ์„ธ๊ท ์„ฑ ๋‡Œ์ˆ˜๋ง‰์—ผ)
(๋งŒ์•ฝ ๋ฉด์—ญ ์–ต์ œ์ œ๋ฅผ ํ•จ๋ถ€๋กœ ์ผ๋‹ค๊ฐ€ ์•Œ๊ณ  ๋ณด๋‹ˆ ์„ธ๊ท  ๊ฐ์—ผ์ด๋ฉด ๋งค์šฐ ์‹ฌ๊ฐํ•ด์ง โ†’ ์„ธ๊ท  ๊ฐ์—ผ์ธ์ง€ ๋ช…ํ™•ํ•œ ๊ฐ๋ณ„ ์ค‘์š”.)

P
  • ํ•ญ์ƒ์ œ ์„ ํƒ? โ†’ ๋‡Œ์ฒ™์ˆ˜์•ก์œผ๋กœ 16s rRNA real-time PCR ๊ฒ€์‚ฌํ•˜์—ฌ ์„ธ๊ท  ๋™์ •
    • Culture๋ณด๋‹ค ๋น ๋ฅด๊ณ  ์ •ํ™•ํ•จ
  • ๋งŒ์•ฝ ํ•ญ์ƒ์ œ๋ฅผ ์ผ๋Š”๋ฐ ์น˜๋ฃŒ ๋ฐ˜์‘์ด ์—†์œผ๋ฉด SRMA ์˜์‹ฌ
    • SRMA (Steroid-Responsive Meningitis-Arteritis) : ๋น„๊ฐ์—ผ์„ฑ(immune-mediated)์œผ๋กœ ์˜ฌ ์ˆ˜ ์žˆ์Œ.
    • Steroid์— ๋ฐ˜์‘ํ•˜์—ฌ ํ˜ธ์ค‘๊ตฌ ๊ฐ์†Œ

โ‡’ BBB ํ†ต๊ณผํ•˜๋Š” ํ•ญ์ƒ์ œ ์ฒ˜๋ฐฉ ์œผ๋กœ ์น˜๋ฃŒ๋จ. (์ž˜ ๊ฑธ์Œ) (๋งŒ์•ฝ ์Šคํ…Œ๋กœ์ด๋“œ ํ•จ๋ถ€๋กœ ์ผ์œผ๋ฉด ์ฃฝ์—ˆ์„ ์ˆ˜๋„..)

(์„ธ๊ท ์ด ๋‡Œ์— ์—ผ์ฆ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค๊ณ  ๋ณด๊ณ ํ•œ ๊ตญ๋‚ด ์ตœ์ดˆ ์ผ€์ด์Šค)

Pug dog-meningoencephalitis

  • Pug์—์„œ GME, NME๊ฐ€ ์ž˜ ์ƒ๊น€.
  • ๋‡Œ์ฒ™์ˆ˜์•ก ์•ˆ์—์„œ macrophages, lymphocytes ๋งŽ์ด ๊ด€์ฐฐ๋จ.

SRMA (CRTS) : ์น˜๋ฃŒ ๋ฐฉํ–ฅ ๋ฐ˜๋Œ€

CRTS (Corticoid-responsive tremor syndrome)

  • Tremor ์ฆ์ƒ์ด ์žˆ์—ˆ๋Š”๋ฐ, ์Šคํ…Œ๋กœ์ด๋“œ ์•ฝ๋ฌผ์— ๋ฐ˜์‘ํ•˜์—ฌ ๋–จ์ง€ ์•Š์Œ.
    • MRI ๊ฒฐ๊ณผ์—๋„ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์ง€๋งŒ, ์Šคํ…Œ๋กœ์ด๋“œ ๋จน์ด๋ฉด ์ข‹์•„์ง€๋”๋ผ
  • ๊ณผ๊ฑฐ์—๋Š” ํ„ธ์ด ํ•˜์–€ ์• ๋“คํ•œํ…Œ๋งŒ ์ƒ๊ฒจ์„œ white shaker syndrome์ด๋ผ๊ณ  ํ–ˆ์œผ๋‚˜,
  • ์š”ํฌ์…”ํ…Œ๋ฆฌ์–ด์ฒ˜๋Ÿผ ํ„ธ์ด ํ•˜์–—์ง€ ์•Š์€ ๊ฐœ์—์„œ๋„ ๋‚˜ํƒ€๋‚˜์„œ โ€œCRTSโ€๋กœ ๋ฐ”๋€œ.

SRMA (Steroid responsive meningitis-arteritis / Suppurative meningitis & arteritis)

(Neutrophil์ด ๋งŽ์•„์„œ suppurativeํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚จ)

  • Steroid ์“ฐ๋ฉด dramaticํ•˜๊ฒŒ ์ข‹์•„์ง. but ์„ธ๊ท  ๊ฐ์—ผ์€ ์•„๋‹Œ์ง€ ํ™•์‹คํžˆ ๊ตฌ๋ณ„ํ•ด์•ผ ํ•จ!
  • MRI์ƒ ๋‚˜ํƒ€๋‚˜๋Š” ์ด์ƒ์€ ์—†์ง€๋งŒ, ๋‡Œ์ฒ™์ˆ˜์•ก์— neutrophil ์ฆ๊ฐ€ (pleocytosis) โ‡’ ๋‡Œ์ˆ˜๋ง‰์—๋งŒ ์—ผ์ฆ์ด ์˜จ ๊ฒƒ์œผ๋กœ ์—ฌ๊ฒจ์ง (meningitis)
  • CRTS = SRMA ๋ผ๊ณ  ์ƒ๊ฐ๋จ.

5์ฃผ์ฐจ (๋…น๊ฐ•) : I

GME (Granulomatous meningoencephalitis)

์œก์•„์ข…์„ฑ ๋‡Œ์ˆ˜๋ง‰์—ผ.

  • ๋น„์—ผ์ฆ์„ฑ ๋‡Œ์ˆ˜๋ง‰์—ผ์„ ์œ ๋ฐœ.
  • Small breed dog์—์„œ ๋งŽ์ด ๋ฐœ์ƒ - ํ‘ธ๋“ค, ๋งํ‹ฐ์ฆˆ, ํผ๊ทธ, ์š”ํฌ์…”ํ…Œ๋ฆฌ์–ด ๋“ฑ
  • ์ Š์€ ๋‚˜์ด์— ๋งŽ์ด ๋ฐœ์ƒํ•˜๋ฉฐ ๋งค์šฐ ์น˜๋ช…์ , ์˜ค๋žœ ๊ธฐ๊ฐ„ ์น˜๋ฃŒ ํ•„์š”.

๐Ÿ“‹ Case 2 : GME

  • Generalized tonic-clonic seizure์ด ์žˆ๋Š” ํ‘ธ๋“ค.
  • ์˜์‹์ด ์—†์Œ, ์‹ ๊ฒฝ ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ ๋‡Œ์งˆ๋ณ‘ ์˜์‹ฌ
  • Brain MRI ๊ฒฐ๊ณผ ์œก์•„์ข…์„ฑ ๋‡Œ์ˆ˜๋ง‰์—ผ ์†Œ๊ฒฌ (์ข…์–‘์ฒ˜๋Ÿผ ๋‡Œ์— ์ƒ๊ธด ํ•˜์–€ ๋ถ€๋ถ„๋“ค)

  • ๋‡Œ์˜ ์ „์ฒด์— multifocalํ•˜๊ฒŒ ๋ณ‘์†Œ๊ฐ€ ์กด์žฌํ•จ. โ†’ ์ž„์ƒ ์ฆ์ƒ, ์˜ˆํ›„๊ฐ€ ๋‚˜์˜๊ฒ ๋‹ค
  • ์ด๋Ÿฌํ•œ ์—ผ์ฆ์„ฑ ๋ณ€ํ™”๋กœ tonic-clonic generalized seizure๋ฅผ ๋ณด์ž„.
  • ์ด๋ ‡๊ฒŒ Forebrain ์— ๋™๋ฐ˜๋˜๋ฉด โ†’ seizure ๊ฐ‘์ž๊ธฐ ๋ฐœ์ƒ, ์žฅ๊ธฐ๊ฐ„ ๋ฉด์—ญ ์–ต์ œ์ œ ์‚ฌ์šฉ.
  • lymphocyte๊ฐ€ ๋‡Œ์˜ ํ˜ˆ๊ด€ ์ฃผ๋ณ€์— ์นจ์œคํ•˜๊ธฐ ๋•Œ๋ฌธ์— ๋น„๊ฐ์—ผ์„ฑ ๋‡Œ์ˆ˜๋ง‰์—ผ์œผ๋กœ ๋ถ„๋ฅ˜, immune-mediate๋‚˜ autoimmune encephalitis๋กœ๋„ ์˜์‹ฌํ•จ.
  • ์‚ฌ๋žŒ์˜ multiple sclerosis (๋‹ค๋ฐœ์„ฑ ๋‡Œ๊ฒฝํ™”์ฆ) ๊ณผ ๊ฐ™์€ ์งˆ๋ณ‘.
S

4y, NM, poodle

  • 5.8kg / 38.3 Cโ€™ / 120bpm
  • CC : Generalized tonic-clonic seizures, Dyspnea
  • RIght-side hemiparesis(ํŽธ์ธต์„ฑ ๋งˆ๋น„)
  • No postural reactions of Rt. side
  • Head tilt
  • No PLR, No MR (Menace response, ์œ„ํ˜‘ ๋ฐ˜์‚ฌ)
  • Horizontal nystagmus, ์–‘์ชฝ ๋ˆˆ์˜ miosis โ‡’ Forebrain sign & vetibular sign, ๋‡Œ ์ „์ฒด์— multifocalํ•œ ๋ณ‘๋ณ€
O
CSF analysis
- Color : ๋ง‘์Œ(colorless)
- Protein : >300mg/dL โ‡’ ๋†’์€ ํŽธ
- Nucleated cell count : >100cells/ฮผl โ‡’ ๋ฐฑํ˜ˆ๊ตฌ ์ฆ๊ฐ€
- Mononuclear pleocytosis (monocytes, lymphocytes ์ฆ๊ฐ€) [2๋ฒˆ์งธ ์‚ฌ์ง„]
- Bacterial, fungal culture, Toxo, Ehrlichia : X
โ‡’ ๊ฐ์—ผ์„ฑ ์›์ธ์ฒด X / ๋‡Œ์— ์—ผ์ฆ์„ฑ ์นจ์œค ์กด์žฌ
MRI
์™ผ์ชฝ ๊ฐ€์ชฝ๋‡Œ์‹ค ์•ˆ ๋ณด์ž„.
์™ผ์ชฝ ๋‡Œ ์ „์ฒด์— ์‹ฌํ•œ ์—ผ์ฆ์„ฑ ์†Œ๊ฒฌ
๋‡Œ์ฒ™์ˆ˜์•ก ์™ธ์˜ ๋ถ€๋ถ„์—์„œ๋„ signal ์ฆ๊ฐ€
๋Œ€๋‡Œ ์ „์ฒด์— multifocalํ•œ ์—ผ์ฆ ๋ฐ˜์‘
Pasted image 20250420103042.png
(๋ชจ๋ฅด๊ฒ ๋‹ค๊ณ ? ๋‚˜๋„ ๊ทธ๋ž˜..)
์™ผ์ชฝ์—์„œ ๊ฐ€์ชฝ๋‡Œ์‹ค ์ž˜ ์•ˆ ๋ณด์ž„, ์—ผ์ฆ์— ์˜ํ•œ edema.

linearํ•˜๊ฒŒ ๊ตญ์†Œ์ ์ธ ์กฐ์˜ ์ฆ๊ฐ• โ‡’ ํ˜ˆ๊ด€์˜ ์—ผ์ฆ์„ ์˜๋ฏธ

* solitary, ๋ช…ํ™•ํ•˜๊ฒŒ ๊ตฌ๋ณ„๋˜๋Š” ์กฐ์˜ ์ฆ๊ฐ• โ‡’ ์ข…์–‘
* linear/diffuse ํ˜•ํƒœ์˜ ์กฐ์˜ ์ฆ๊ฐ• โ‡’ ํ˜ˆ๊ด€ ์—ผ์ฆ
Histopathology
ํ˜ˆ๊ด€ ์ฃผ๋ณ€์œผ๋กœ lymphocyte ์นจ์œค๋˜์–ด ์žˆ์Œ.
(Immune-mediated)
A
  • forebrain sign & vetibular sign
  • CSF์— ๋ฐฑํ˜ˆ๊ตฌ, ๋‹จํ•ต๊ตฌ ๊ณ„ํ†ต ์„ธํฌ ์ฆ๊ฐ€
  • MRI์ƒ ๋‡Œ ์ „๋ฐ˜์— multifocalํ•œ ์—ผ์ฆ

โ‡’ Dx) GME (Granulomatous Meningoencephalitis) (I - Immune mediated)

P

GME ์ง„๋‹จ ์‹œ combination therapy

  • prednisolone (1mg/kg BID PO) : ์—ผ์ฆ ๊ฐ์†Œ
    • ์žฅ๊ธฐ๊ฐ„ ์‚ฌ์šฉ ์‹œ ์˜์ธ์„ฑ cushing ์ฆ์ƒ (PUPD, ๋ฐฐ๊ฐ€ ๋นต๋นต, ํƒˆ๋ชจ, ํ”ผ๋ถ€ ๊ฑด์กฐ/์–‡์•„์ง), ๋‹น๋‡จ, ๊ฐ๋ง‰ ๊ถค์–‘, ํ”ผ๋ถ€ ์นผ์Š˜ ์นจ์ฐฉ
    • ์žฅ๊ธฐ๊ฐ„ ์‚ฌ์šฉ ์‹œ ์šฉ๋Ÿ‰์„ ๋‚ฎ๊ฒŒ ์จ์•ผ ํ•จ (1mg/kg ์ดํ•˜)
  • ๊ทธ ์™ธ์—๋„ GME ํ™˜์ž์—์„œ๋Š”..
    • cyclosporine (5-10mg/kg BID PO) : ๋ฉด์—ญ ์–ต์ œ์ œ (์žฅ๊ธฐ์ด์‹ ๊ฑฐ๋ถ€๋ฐ˜์‘ ์–ต์ œ ๋“ฑ), ์ง€์šฉ์„ฑ ์•ฝ๋ฌผ๋กœ ํšŒ์‚ฌ๋งˆ๋‹ค ํก์ˆ˜์œจ์ด ๋‹ค๋ฅด๋ฏ€๋กœ ํ˜ˆ์ค‘ ๋†๋„ ์ธก์ •ํ•˜๋ฉฐ ์‚ฌ์šฉํ•ด์•ผ ํ•จ.
    • misoprostol (3ฮผg/kg BID PO) : ์œ„๋ฒฝ ๋ณดํ˜ธ (steroid์— ์˜ํ•œ ์œ„๊ถค์–‘ ์˜ˆ๋ฐฉ)
    • silymarin, sucralfate, UDCA : ์ ๋ง‰ ๋ฐ ๊ฐ„ ๋ณดํ˜ธ, ๋‹ด์ฆ™ ๋ฐฐ์„ค ์ด‰์ง„ (steroid์— ์˜ํ•œ ๊ฐ„๋…์„ฑ ์˜ˆ๋ฐฉ)

Progress note

  • 1์ฐจ Medication | PDS ํˆฌ์—ฌ โ†’ ์ž„์ƒ์ฆ์ƒ ๊ฐœ์„ , ataxia/recumbency ์ƒํƒœ โ†’ ๋‹ค์‹œ ์ผ์–ด๋‚˜ ๊ฑธ์Œ
  • Combination therapy | PDS + cyclosporine ํˆฌ์—ฌ
  • Progress | mental status & neurologic sign ๊ฐœ์„ , ํŠนํžˆ seizure ๊ฐ์†Œ

โ‡’ P) ์—ผ์ฆ์— ์˜ํ•œ active seizure์— ํ•ด๋‹นํ•˜๋Š” ๊ฒƒ์„ ํ™•์ธ, ํ•ญ๊ฒฝ๋ จ์ œ์™€ ๊ธฐ์ €์งˆํ™˜ ์น˜๋ฃŒ ์ด์–ด๋‚˜๊ฐ€์•ผ ํ•จ.

๋‹ค์–‘ํ•œ meningoencephalitis

  • GME (Granulomatous meningoencephalitis) : ์ฃผ๋กœ ๋ฆผํ”„๊ตฌ๊ฐ€ ๋ณ‘๋ณ€์— ์นจ์œคํ•˜์—ฌ ๋น„๊ฐ์—ผ์„ฑ์œผ๋กœ ๋ฐœ์ƒํ•œ ๋‡Œ์ˆ˜๋ง‰์—ผ.
    • Granulomatous = lymphocytes, macrophages, monocytes, neutrophils๊ฐ€ ํ˜ผ์žฌ๋˜์–ด ๋‚˜ํƒ€๋‚œ ๊ตฌ์กฐ.
    • ์ด๋Ÿฐ ์œก์•„์ข…์„ฑ ์—ผ์ฆ์ด CNS์— ๋ถ„ํฌํ•จ.
  • NME (Necrotisizing meningoencephalitis) : ๋ฆผํ”„๊ตฌ๊ฐ€ ์นจ์œคํ•˜์—ฌ ๋‡Œ ์ผ๋ถ€์— ๊ดด์‚ฌ๊ฐ€ ์ง„ํ–‰, GME๋ณด๋‹ค ์•…ํ™”๋œ ์†Œ๊ฒฌ.
    • Pug meningoencephalitis : pug์— ํ˜ธ๋ฐœํ•˜์—ฌ ๋ถ™์€ ์ด๋ฆ„, ๊ณผ๊ฑฐ์— ์‚ฌ์šฉ
  • CDV-meningoencephalitis : Distemper virus์— ์˜ํ•œ viral meningoencephalitis
    • Mucoencephalitis : ์ฃผ๋กœ white matter์— ์ ์•ก์„ฑ ์—ผ์ฆ์ด ๋‚˜ํƒ€๋‚˜์„œ ๋ถ™์€ ์ด๋ฆ„
  • ์›์ธ์„ ์ฐพ์ง€ ๋ชปํ•œ ๊ฒฝ์šฐ, MUE (Meningoencephalitis or unknown etiology)
  • Pons-medullary GME : seizure๋Š” ๋ฐœ์ƒํ•˜์ง€ ์•Š๊ณ  ํ˜ธํก ๊ณค๋ž€, ์ž์œจ์‹ ๊ฒฝ๊ณ„ ์ด์ƒ, cranial nerve ์ด์ƒ, ๋นˆ๋งฅ์„ฑ ๋ถ€์ •๋งฅ์ด ๋ฐœ์ƒํ•จ.

Types of GME

Types
Ocular formOptic nerve์˜ ์—ผ์ฆ์ด optic neuritis๋ฅผ ์œ ๋ฐœํ•˜์—ฌ ์‹œ๊ฐ ์žฅ์• 
Focal formํ•œ ๊ตฐ๋ฐ์— ๋ณ‘๋ณ€์ด ์žˆ๋Š” ๊ฒฝ์šฐ
Multifocal form์—ฌ๋Ÿฌ ๊ตฐ๋ฐ ๋ณ‘๋ณ€์ด ์žˆ๋Š” ๊ฒฝ์šฐ
Disseminated form๋‡Œ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋ˆˆ, optic nerve, brain stem, spinal cord ๋“ฑ์— ๋‹ค์–‘ํ•˜๊ฒŒ ๋ฐœ์ƒํ•œ ๊ฒฝ์šฐ
์‚ฌ์ง„์œผ๋กœ ๋ณด๋Š” ๋‹ค์–‘ํ•œ ๋‡Œ์ˆ˜๋ง‰์—ผ ์ผ€์ด์Šค

Sagittal T2-weighted image of GME case
- frontal lobe์— solitaryํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚œ hyperintense lesion
โ‡’ Focal GME

enhanced T1 & T2 weighted image
- ๋‡Œ ์•ˆ์ชฝ๊นŒ์ง€ multifocal lesions ์žˆ์Œ
- ์ข…์–‘๊ณผ ํ—ท๊ฐˆ๋ฆฌ์ง€ ์•Š๋„๋ก ์ฃผ์˜.

โ‡’ Multifocal GME

GME case
- ์™ผ์ชฝ ๋‡Œ์— ์ „๋ฐ˜์ ์œผ๋กœ ์‹ฌํ•œ ์—ผ์ฆ ์†Œ๊ฒฌ
- autopsy ๊ฒฐ๊ณผ, cerebral parenchyma์˜ swelling
- ๋น„๋Œ€์นญ์ ์ธ ์ธก๋‡Œ์‹ค ๊ด€์ฐฐ๋จ

GME case์˜ histopathology
- A : perivascular cuffings
(ํ˜ˆ๊ด€ ์ฃผ๋ณ€์œผ๋กœ ๊ฒ€๊ฒŒ ๋œ ๋ถ€๋ถ„๋“ค์ด ๋งŽ์Œ)
- B : lymphoid cells ์นจ์œค
(ํ˜ˆ๊ด€ ๋‚ด ํ•˜์–€ ๊ณตํฌ๋กœ ๋‚˜ํƒ€๋‚˜๋Š” ์ง€๋ฐฉ ๊ตฌ์กฐ๊ฐ€ ํฌ๋„์•Œ ๊ฐ™์ด ํ˜ˆ๊ด€์„ ์‹ธ๊ณ  ์žˆ์Œ.)

NME (YT)
- T1 image์—์„œ๋Š” hyposignal (์–ด๋‘ก๊ฒŒ ๋ณด์ž„)
- T2 image์—์„œ๋Š” hypersignal (๋ฐ๊ฒŒ ๋ณด์ž„)
โ‡’ NME ์˜ ํŠน์ง•!

* GME๋Š” T1์—์„œ isoignal, T2์—์„œ hypersignal

NME case
- ์˜ค๋ฅธ์ชฝ ๋‡Œ์˜ temporal ์˜์—ญ์— ๋งŽ์€ ์—ผ์ฆ ํ™•์ธ
- ๋ถ€๊ฒ€ ๊ฒฐ๊ณผ gray matter ์ผ๋ถ€๊ฐ€ ์™„์ „ํžˆ ๊ดด์‚ฌ๋œ ๊ฒƒ์„ ํ™•์ธ

Therapy & Prognosis of GME

์•ฝ๋ฌผ
Steroid (Prednisolone)- ํ•ญ์—ผ ํšจ๊ณผ๋กœ ์ข‹์Œ
- ์žฅ๊ธฐ๊ฐ„ ์‚ฌ์šฉ ์‹œ ์˜์ธ์„ฑ Cushing ์œ„ํ—˜
- ์ ์ฐจ ๊ฐ๋Ÿ‰ํ•˜๋ฉด์„œ ์ตœ์†Œ ์šฉ๋Ÿ‰์œผ๋กœ ์œ ์ง€
Cytosine arabinoside- ์˜ค๋žซ๋™์•ˆ ์‚ฌ์šฉ๋œ ํ•ญ์•”์ œ/๋ฉด์—ญ์–ต์ œ์ œ
- PDS์™€ ํ•จ๊ป˜ ์‚ฌ์šฉ, ๋˜๋Š” ๋‹จ๋…์œผ๋กœ ๋ฉด์—ญ ํ•ญ์ง„์— ์˜ํ•œ GME ์น˜๋ฃŒ์— ์‚ฌ์šฉ
- BBB๋ฅผ ํ†ต๊ณผํ•  ์ˆ˜ ์žˆ์Œ
- ๋ถ€์ž‘์šฉ : ๊ณจ์ˆ˜์–ต์••, ๊ตฌํ† , ์„ค์‚ฌ, ํƒˆ๋ชจ ๋“ฑ
- ํ”ผํ•˜์ฃผ์‚ฌ, 50mg/mยฒ BID๋กœ ์ดํ‹€ ์—ฐ์†, 3์ฃผ์— 1๋ฒˆ ๊ฐ€๋Šฅ
- ์•ฝ๋ฌผ์ด ํ”ผ๋ถ€๋ฅผ ํ†ต๊ณผํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์žฅ๊ฐ‘์„ ๋ผ๊ณ  ํˆฌ์—ฌ
Procarbazine- PDS ๋ณด์กฐ ์š”๋ฒ•, ๋‹จ๋…์œผ๋กœ๋„ ์‚ฌ์šฉ ๊ฐ€๋Šฅ
- ํ•ญ์ข…์–‘ ์•ฝ๋ฌผ, ์ง€์šฉ์„ฑ์œผ๋กœ BBB ํ†ต๊ณผ ๊ฐ€๋Šฅ
- 25-50mg/mยฒ/day PO
Cyclosporine A- IL-2๋ฅผ ๋น„๋กฏํ•œ cytokine ํ•ฉ์„ฑ ์–ต์ œ
- ์‚ฌ๋ฃŒ ์„ญ์ทจ 1์‹œ๊ฐ„ ์ „ or 2์‹œ๊ฐ„ ํ›„์— ๋จน์—ฌ์•ผ ์ž˜ ํก์ˆ˜๋จ
- ์•ˆ์ „ํ•œ ํŽธ์ด์ง€๋งŒ, ํ˜ˆ์ค‘ ๋†๋„๊ฐ€ ๋†’๊ฒŒ(>3000ng/ml) ์˜ค๋ž˜ ํˆฌ์—ฌํ•˜๋ฉด ์‹ ๋…์„ฑ, ๊ฐ„๋…์„ฑ
- ํ˜ˆ์ค‘ ๋†๋„ 200-400ng/ml์„ ์œ ์ง€ํ•˜๋ฉด ์žฅ๊ธฐ ์‚ฌ์šฉ ๊ฐ€๋Šฅ,
ํˆฌ์—ฌ 2์ฃผ ํ›„ ํ˜ˆ์ค‘๋†๋„ ์ธก์ • ๊ถŒ์žฅ.
- ๋ถ€์ž‘์šฉ : excessive shedding, gingival hyperplasia, hypertrichosis(ํ„ธโ†‘), ๊ตฌํ† , ์„ค์‚ฌ, ์‹์š•๋ถ€์ง„
Cyclosporine
+ Ketoconazole
- Cyclosporin A 5mg/kg + Ketoconazole 8mg/kg SID
โ‡’ cyclosporine A ๋†๋„๊ฐ€ ์ž˜ ์œ ์ง€๋จ.
- cyclosporine์ด ๋น„์‹ธ์„œ ์ด๋ ‡๊ฒŒ ๋ณ‘์šฉํ•˜๊ธฐ๋„ ํ•จ.
- ํ‘œ์  ๋†๋„์— ๋„๋‹ฌํ–ˆ๋Š”์ง€ ํ™•์ธํ•˜๊ณ  ์•ฝ๋ฌผ ํˆฌ์—ฌ๋Ÿ‰ ์กฐ์ ˆ
- Ketoconazole์€ ๊ฐ„๋…์„ฑ์ด ์žˆ์œผ๋ฏ€๋กœ ๊ฐ„์ด ์•ˆ ์ข‹์€ ํ™˜์ž์—์„œ๋Š” X
Leflunomide- ๋ฉด์—ญ์–ต์ œ์ œ, MMF๋„ ์‚ฌ์šฉ ๊ฐ€๋Šฅ
- 4mg/kg SID